He will help deliver the 100,000 Genomes Project
Flagship organisation Genomics England has appointed its first CEO, global genomics pioneer Professor John Mattick AO FAA FAHMS FTSE.
Genomics England was set up to deliver the 100,000 Genomes Project – a project that will sequence 100,000 whole genomes from NHS patients with rare diseases, their families, and patients with common cancers.
Established in 2013, the project is currently headed by Sir John Chisholm, who will hand over executive responsibility to Professor Mattick in June.
“I have spent my professional life exploring the human genome and promoting its importance to understanding human biology, which I regard as the great quest of our age,” Professor Mattick said.
“It very much feels like my career to date has been preparing me for this role and it is an opportunity I intend to fully realise – for the benefit of patients, society and the UK economy.”
Professor Mattick has an extensive and globally-renowned career championing genome research. He has led the Garvan Institute of Medical Research since 2012 and, under his management, brought genomics, bioinformatics and big data to the centre of the institute’s research programs.
Among his many achievements, he received international recognition for his work showing how most of the human genome is devoted to an extensive RNA regulatory system that organises human development – rather than being evolutionary “junk”.
While in the UK, Professor Mattick will continue his academic career at the University of Oxford’s Green Templeton College.
Promoting Australia's advancement through technology